Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Guardant Health, Inc.    GH

GUARDANT HEALTH, INC.

(GH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/20/2020 10/21/2020 10/22/2020 10/23/2020 10/26/2020 Date
101.92(c) 99.96(c) 102.69(c) 104.71(c) 103.15 Last
755 434 883 226 574 254 615 953 169 950 Volume
-0.80% -1.92% +2.73% +1.97% -1.49% Change
More quotes
Financials (USD)
Sales 2020 279 M - -
Net income 2020 -158 M - -
Net cash position 2020 865 M - -
P/E ratio 2020 -65,3x
Yield 2020 -
Sales 2021 380 M - -
Net income 2021 -119 M - -
Net cash position 2021 747 M - -
P/E ratio 2021 -82,3x
Yield 2021 -
Capitalization 10 431 M 10 431 M -
EV / Sales 2020 34,3x
EV / Sales 2021 25,5x
Nbr of Employees 622
Free-Float 92,2%
More Financials
Company
Guardant Health, Inc. is a precision oncology company. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. It provides Guardant Health Oncology Platform. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. Its liquid biopsy tests fuels its programs developing tests for recurrence and early detection, LUNAR-1 and... 
More about the company
Notations Surperformance© of Guardant Health, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about GUARDANT HEALTH, INC.
10/16GUARDANT HEALTH : Announces Webcast of Third Quarter Financial Results on Novemb..
BU
10/15GUARDANT HEALTH : Announces Closing of Public Offering of Common Stock, Includin..
BU
10/13GUARDANT HEALTH, INC. : Other Events (form 8-K)
AQ
10/07GUARDANT HEALTH : Announces Pricing of Public Offering of Common Stock by Sellin..
BU
10/06GUARDANT HEALTH : Announces Proposed Public Offering of Common Stock by Selling ..
BU
10/05GUARDANT HEALTH : Large-Scale Study Shows Guardant360 Liquid Biopsy Accelerates ..
BU
09/01Guardant Health to Participate in Morgan Stanley 2020 Healthcare Conference
GL
08/24Guardant Health Receives FDA Emergency Use Authorization for its Guardant-19 ..
GL
08/10Guardant Health to Participate in Upcoming August Investor Conferences
GL
08/07GUARDANT HEALTH : Guardant360ģ CDx First FDA-Approved Liquid Biopsy for Comprehe..
AQ
08/06GUARDANT HEALTH : 2Q Earnings Snapshot
AQ
08/06GUARDANT HEALTH : Management's Discussion and Analysis of Financial Condition an..
AQ
08/06GUARDANT HEALTH, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
08/06Guardant Health Reports Second Quarter 2020 Financial Results
GL
07/30Guardant Health Announces Collaboration with Radius Health to Develop Liquid ..
GL
More news
News in other languages on GUARDANT HEALTH, INC.
2019Vision Fund veut garantir un prêt par ses parts dans Uber
More news
Chart GUARDANT HEALTH, INC.
Duration : Period :
Guardant Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GUARDANT HEALTH, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Average target price 116,78 $
Last Close Price 104,71 $
Spread / Highest target 24,2%
Spread / Average Target 11,5%
Spread / Lowest Target -4,50%
EPS Revisions
Managers
NameTitle
Helmy Eltoukhy Chief Executive Officer & Director
AmrAli H. Talasaz Chairman, President & Chief Operations Officer
Derek A. Bertocci Chief Financial Officer
Kumud Kalia Chief Information Officer
Darya Chudova Senior Vice President-Technology
Sector and Competitors
1st jan.Capitalization (M$)
GUARDANT HEALTH, INC.34.00%10 431
EXACT SCIENCES CORPORATION18.62%16 473
BGI GENOMICS CO., LTD.93.35%7 868
ADAPTIVE BIOTECHNOLOGIES CORPORATION65.44%6 722
SEEGENE INC--.--%6 083
INVITAE CORPORATION180.60%5 965